Polypropylene Versus Polyglactin in Upper Limb Subcuticular Skin Closure

NCT07582679 · tracked via the Priya Life Science Egypt tracker

Sponsor

Shebin El-Kom Teaching Hospital

Phase

Not applicable

Started

2026-05

Last updated

2026-05-13

Condition(s) studied

Compare Cosmetic Outcomes of Subcuticular Skin Closure Using Polypropylene and Polyglactin

Investigational drug(s) / intervention(s)

Upper limb wounds subcuticular skin closure with PolypropyleneUpper limb wounds subcuticular skin closure with Polyglactin

Upper limb wounds subcuticular skin closure with Polypropylene: Upper limb wounds subcuticular skin closure

Upper limb wounds subcuticular skin closure with Polyglactin: Upper limb wounds subcuticular skin closure with Polyglactin

Study summary

Polypropylene versus Polyglactin in Upper Limb Subcuticular Skin Closure

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adults aged ≥18 years * Patients undergoing any surgical procedure involving the upper limb * Procedures performed in either elective or emergency settings * Wounds suitable for primary subcuticular skin closure * Ability to provide informed consent Exclusion Criteria: * Heavily contaminated or infected wounds * Patients with uncontrolled diabetes mellitus, chronic steroid use, immunosuppression or peripheral vascular disease * Crush injuries and wounds with significant tissue loss * Known allergy to suture material * Delayed primary closure wounds

Primary outcome measure(s)

Cosmetic outcome measured using the Patient and Observer Scar Assessment Scale (POSAS) total score (range 6-60) — Baseline
Scar quality will be evaluated using the Patient and Observer Scar Assessment Scale (POSAS), which includes both patient-reported and observer-reported components. Each item is scored from 1 to 10, with total scores ranging from 6 to 60, where lower scores indicate better cosmetic outcome.

Trial sites (1)

Facility	City	Region	Status
Shebin El Koum teaching Hospital	Menoufia Governorate	Egypt	Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07582679 on ClinicalTrials.gov ↗ ← All trials in Egypt